Yasuo Takeuchi, Director, Representative Executive Officer,President and CEO Chikashi Takeda, Executive Officer and Chief Financial Officer PLAY LIST from the beginning Consolidated Financial Results for Fiscal 2021 and Full-Year Forecasts for Fiscal 2022 Disclaimer @ 01 Consolidated Financial Results and Business Review for Fiscal 2021 (FY Ending March 31, 2021) @ @ @ @ @ @ @ 02 Forecasts for Fiscal 2022 @ @ Management Policy for Fiscal 2022 01 Transforming into a Truly Global Medtech Company @ @ 02 Business Review for Fiscal 2021 @ @ @ 03 Management Policy for Fiscal 2022 @ @ @ @ Appendix @ @ @ @ @ Q&A Q&A 1 Q&A 2 Q&A 3 Q&A 4 Q&A 5 Q&A 6 Q&A 7 Q&A 8 Q&A 9 Back Next